EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model

Ayman A Abdel-Wahab, Dalia A Shafey, Sahar M Selim, Soraya A Sharaf, Khloud K Mohsen, Dina M Allam, Sally W Elkhadry, Marwa A Gouda

Parasitology Research · 2024

DOI: 10.1007/s00436-024-08280-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasitology Research, 2024. Verfasst von Ayman A Abdel-Wahab und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Parasitology, National Liver Institute, Menoufia University, Menoufia, Egypt. Hauptthemen laut MEDLINE: Spiramycin, Polysaccharides, Nanoparticles, Disease Models, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minufiya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite being the initial choice for treating toxoplasmosis, sulfadiazine and pyrimethamine have limited effectiveness in eliminating the infection and were linked to a variety of adverse effects. Therefore, the search for new effective therapeutic strategies against toxoplasmosis is still required. The current work is the first research to assess the efficacy of spiramycin-loaded maltodextrin nanoparticles (SPM-loaded MNPs) as a novel alternative drug therapy against toxoplasmosis in a murine model. Fifty laboratory-bred Swiss albino mice were divided into five groups: normal control group (GI, n = 10), positive control group (GII, n = 10), orally treated with spiramycin (SPM) alone (GIII, n = 10), intranasal treated with SPM-loaded MNPs (GIV, n = 10), and orally treated with SPM-loaded MNPs (GV, n = 10). Cysts of Toxoplasma gondii ME-49 strain were used to infect the mice. Tested drugs were administered 2 months after the infection. Drug efficacy was assessed by counting brain cysts, histopathological examination, and measures of serum CD19 by flow cytometer. The orally treated group with SPM-loaded MNPs (GV) showed a marked reduction of brain cyst count (88.7%), histopathological improvement changes, and an increasing mean level of CD19 (80.2%) with significant differences. SPM-loaded MNPs showed potent therapeutic effects against chronic toxoplasmosis. Further research should be conducted to assess it in the treatment of human toxoplasmosis, especially during pregnancy. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpiramycinPolysaccharidesNanoparticlesDisease Models, AnimalToxoplasmosis, AnimalAnimalsMiceToxoplasmaFemaleBrainAntiprotozoal AgentsToxoplasmosisDrug Carriers

Stichwörter der Autor:innen

Maltodextrin nanoparticlesSpiramycinToxoplasmosisTreatment

Substanzen

SpiramycinPolysaccharidesmaltodextrinAntiprotozoal AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Clinical and Molecular Parasitology, National Liver Institute, Menoufia University, Menoufia, Egypt.
  • Department of Clinical and Molecular Parasitology, National Liver Institute, Menoufia University, Menoufia, Egypt. drkhloud.kamel@liver.menofia.edu.eg.
  • Department of Pathology, Faculty of Medicine, Menoufia University, Shibin Elkom, Egypt.
  • Department of Epidemiology and Preventive Medicine, National Liver Institute, Menoufia University, Menoufia, Egypt.

Förderung

  • Minufiya University

Zitieren

APA

Abdel-Wahab, A. A., Shafey, D. A., Selim, S. M., Sharaf, S. A., Mohsen, K. K., Allam, D. M., Elkhadry, S. W., & Gouda, M. A. (2024). Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model. Parasitology Research. https://doi.org/10.1007/s00436-024-08280-4

Vancouver

Abdel-Wahab AA, Shafey DA, Selim SM, Sharaf SA, Mohsen KK, Allam DM, et al. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model. Parasitology Research. 2024. doi:10.1007/s00436-024-08280-4

BibTeX
@article{AbdelWahab2024,
  author = {Abdel-Wahab, Ayman A and Shafey, Dalia A and Selim, Sahar M and Sharaf, Soraya A and Mohsen, Khloud K and Allam, Dina M and Elkhadry, Sally W and Gouda, Marwa A},
  title = {Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model},
  journal = {Parasitology Research},
  year = {2024},
  doi = {10.1007/s00436-024-08280-4}
}
Kostenlos starten →